Micro-Leads Overview

  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $10M
Latest Deal Amount
  • Investors
  • 6

Micro-Leads General Information

Description

Developer of a wireless implantable neuromodulation device intended to offer arbitrary bi-phasic pulses and kilohertz blocking patterns. The company's platform offers programming of the patterns wirelessly through a browser software interface with subcutaneous, implantable peripheral nerve stimulators, tether-free animal operation, adjustable anodic and cathodic amplitudes, unobtrusive wireless charging pad accessory, backpack and portable stimulators, enabling patients to experience advanced spinal-cord stimulation therapy to cure back pains and other related disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Monitoring Equipment
Primary Office
  • 255 Elm Street
  • Suite 300
  • Somerville, MA 02144
  • United States
+1 (617) 000-0000

Micro-Leads Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Micro-Leads Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 03-Dec-2019 $10M Completed Generating Revenue
4. Grant 10-Jan-2017 000 Completed Startup
3. Grant 01-Jan-2017 00.000 Completed Startup
2. Grant 01-Jan-2017 $1.13M Completed Startup
1. Accelerator/Incubator 11-Mar-2016 Completed Startup
To view Micro-Leads’s complete valuation and funding history, request access »

Micro-Leads Executive Team (1)

Name Title Board Seat Contact Info
Bryan McLaughlin Ph.D Founder & Chief Executive Officer
To view Micro-Leads’s complete executive team members history, request access »

Micro-Leads Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
GlaxoSmithKline Corporation 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »